供体肠道菌群的分类组成是影响难治性溃疡性结肠炎粪菌移植疗效的主要因素
该开放对照试验在27例难治性溃疡性结肠炎患者中比较重复粪菌移植(FMT组17例)与单纯抗生素预处理(AB组10例)为期90天的疗效,并分析供体与患者因素。FMT组59%应答、24%缓解,应答主要受供体菌群分类组成影响,高细菌丰富度及特定菌属丰度高的供体更易诱导缓解;单用抗生素耐受性差,可能因肠道菌群丰富度持续下降。
要点
- FMT组17例中10例(59%)应答、4例(24%)缓解。
- 供体高细菌丰富度及高Akkermansia muciniphila、未分类Ruminococcaceae、Ruminococcus spp.丰度更易诱导缓解。
- 单用抗生素预处理耐受性差,可能因肠道菌群丰富度持续下降。
核心结论
- 供体肠道菌群的分类组成是影响难治性溃疡性结肠炎患者粪菌移植疗效的主要因素。
- 设计特定的微生物制剂可能为溃疡性结肠炎带来新的治疗方法。
研究设计与样本
- 开放对照试验,在27例难治性溃疡性结肠炎患者中比较重复粪菌移植(FMT组,n=17)与单纯抗生素预处理(AB组,n=10),观察90天。
- 采用基于16SrRNA基因的菌群分析检测供体与患者粪便样本。
主要发现
- FMT组10/17(59%)患者应答,4/17(24%)患者缓解。
- 缓解供体 vs 未应答供体的细菌丰富度(观察物种数)为946 ± 93 vs 797 ± 181(15367 rps)。
- 缓解供体 vs 未应答供体的Akkermansia muciniphila相对丰度为3.3 ± 3.1% vs 0.1 ± 0.2%。
- 缓解供体 vs 未应答供体的未分类Ruminococcaceae相对丰度为13.8 ± 5.0% vs 7.5 ± 3.7%。
- 缓解供体 vs 未应答供体的Ruminococcus spp.相对丰度为4.9 ± 3.5% vs 1.0 ± 0.7%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Faecal microbiota transplantation is an experimental approach for the treatment of patients with ulcerative colitis. Although there is growing evidence that faecal microbiota transplantation is effective in this disease, factors affecting its response are unknown. AIMS: To establish a faecal microbiota transplantation treatment protocol in ulcerative colitis patients, and to investigate which patient or donor factors are responsible for the treatment success. METHODS: This is an open controlled trial of repeated faecal microbiota transplantation after antibiotic pre-treatment (FMT-group, n = 17) vs antibiotic pre-treatment only (AB-group, n = 10) in 27 therapy refractory ulcerative colitis patients over 90 days. Faecal samples of donors and patients were analysed by 16SrRNA gene-based microbiota analysis. RESULTS: In the FMT-group, 10/17 (59%) of patients showed a response and 4/17 (24%) a remission to faecal microbiota transplantation. Response to faecal microbiota transplantation was mainly influenced by the taxonomic composition of the donor's microbiota. Stool of donors with a high bacterial richness (observed species remission 946 ± 93 vs no response 797 ± 181 at 15367 rps) and a high relative abundance of Akkermansia muciniphila (3.3 ± 3.1% vs 0.1 ± 0.2%), unclassified Ruminococcaceae (13.8 ± 5.0% vs 7.5 ± 3.7%), and Ruminococcus spp. (4.9 ± 3.5% vs 1.0 ± 0.7%) were more likely to induce remission. In contrast antibiotic treatment alone (AB-group) was poorly tolerated, probably because of a sustained decrease of intestinal microbial richness. CONCLUSIONS: The taxonomic composition of the donor's intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in ulcerative colitis patients. The design of specific microbial preparation might lead to new treatments for ulcerative colitis.
引用
- Kump P, Wurm P, Gröchenig HP, et al. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis. Aliment Pharmacol Ther. 2017. PMID: 29052237. doi:10.1111/apt.14387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。